 MyMD Pharmaceuticals Inc NASDAQ: MYMD announces that a human cell research study of its lead compound MYMD-1 found the drug to effectively suppress the cytokine storm, a major cause of severity and death in COVID-19 patients. Cytokine storm causes an overreaction of the immune system that can cause the body to attack its tissues and organs, leading to a high proportion of deaths from COVID-19. 